Visionary Horizons, LLC Genprex, Inc. Transaction History

Visionary Horizons, LLC

  • $150 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024
BUY
$0.19 - $0.37 $5,700 - $11,100
30,000 New
30,000 $6.9 Million

Others Institutions Holding GNPX

# of Institutions
2
Shares Held
600
Call Options Held
0
Put Options Held
0
View Full List

About Genprex, Inc.

GNPX Quotes by TradingView
  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $39.9M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track Visionary Horizons, LLC Portfolio

Follow Visionary Horizons, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Visionary Horizons, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Visionary Horizons, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email